Suchergebnisse - "Farajnia, Safar"

PubPharm (8)

1

Cytoplasmic Chaperones Enhance Soluble Expression of Anti-EGFR huscFv in Escherichia coli

enthalten in: Iranian journal of biotechnology | 2020

von Nazari, A. | Farajnia, S. | Zahri, S. | +3

2

Synergistic Effect of Novel EGFR Inhibitor AZD8931 and p38α siRNA in Lung Adenocarcinoma Cancer Cells

enthalten in: Anti-cancer agents in medicinal chemistry | 2019

von Zarredar, H. | Farajnia, S. | Ansarin, K. | +3

3

Expression and Evaluation of HuscFv Antibody -PE40 Immunotoxin for Target Therapy of EGFR-Overexpressing Cancers

enthalten in: Iranian journal of biotechnology | 2018

von Falahatgar, D. | Farajnia, S. | Zarghami, N. | +4

4

Potential Molecular Targets in the Treatment of Lung Cancer Using siRNA Technology

enthalten in: Cancer investigation | 2018

von Zarredar, H. | Ansarin, K. | Baradaran, B. | +2

5

Design, expression and evaluation of a novel humanized single chain antibody against epidermal growth factor receptor (EGFR)

enthalten in: Protein expression and purification | 2016

von Akbari, B. | Farajnia, S. | Zarghami, N. | +4

6

Development and evaluation of a single domain antibody against human epidermal growth factor receptor (EGFR)

enthalten in: Protein expression and purification | 2016

von Ahdi Khosroshahi, S. | Farajnia, S. | Ghiamirad, M. | +4

7

Chaperone-Assisted Soluble Expression of a Humanized Anti-EGFR ScFv Antibody in E. Coli

enthalten in: Advanced pharmaceutical bulletin | 2015

von Veisi, K. | Farajnia, S. | Zarghami, N. | +4

8

Recent advances in head and neck squamous cell carcinoma--a review

enthalten in: Clinical biochemistry | 2014

von Safdari, Y. | Khalili, M. | Farajnia, S. | +3

1
[1]